HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ting Zhao Selected Research

picolinic acid (chromium picolinate)

3/2018Pharmacokinetics and bioavailability of chromium malate and its influence on trace metals absorption after oral or intravenous administration.
11/2015Evaluation of 90-day Repeated Dose Oral Toxicity, Glycometabolism, Learning and Memory Ability, and Related Enzyme of Chromium Malate Supplementation in Sprague-Dawley Rats.
11/2015Evaluation of the Reproductive Toxicity, Glycometabolism, Glycometabolism-Related Enzyme Levels and Lipid Metabolism of Chromium Malate Supplementation in Sprague-Dawley Rats.
7/2015Effects of chromium malate on glycometabolism, glycometabolism-related enzyme levels and lipid metabolism in type 2 diabetic rats: A dose-response and curative effects study.
1/2015Type 2 diabetic rats on diet supplemented with chromium malate show improved glycometabolism, glycometabolism-related enzyme levels and lipid metabolism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ting Zhao Research Topics

Disease

89Neoplasms (Cancer)
04/2022 - 11/2002
18Inflammation (Inflammations)
06/2022 - 11/2005
16Epilepsy (Aura)
10/2022 - 01/2012
16Infections
01/2022 - 06/2009
13Neoplasm Metastasis (Metastasis)
12/2021 - 10/2008
13Leukemia
11/2019 - 05/2010
12Insulin Resistance
03/2021 - 08/2013
11Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
05/2021 - 09/2009
10Breast Neoplasms (Breast Cancer)
10/2021 - 03/2011
10Sepsis (Septicemia)
12/2018 - 01/2012
8Lung Neoplasms (Lung Cancer)
09/2022 - 04/2011
8Carcinogenesis
10/2021 - 02/2017
8Huntington Disease (Huntington's Disease)
12/2017 - 03/2015
7Body Weight (Weight, Body)
05/2022 - 12/2011
7Ischemic Stroke
10/2021 - 01/2014
7Stomach Neoplasms (Stomach Cancer)
08/2020 - 10/2013
6Type 2 Diabetes Mellitus (MODY)
03/2021 - 11/2016
6Seizures (Absence Seizure)
01/2021 - 01/2012
6Shock
03/2019 - 01/2011
6Neurodegenerative Diseases (Neurodegenerative Disease)
12/2017 - 03/2015
6Graft vs Host Disease (Graft-Versus-Host Disease)
09/2014 - 05/2010
5Alzheimer Disease (Alzheimer's Disease)
10/2022 - 08/2014
5Non-alcoholic Fatty Liver Disease
07/2022 - 01/2015
5Hypoxia (Hypoxemia)
01/2022 - 02/2012
5Hepatocellular Carcinoma (Hepatoma)
01/2022 - 11/2002
5Pancreatic Neoplasms (Pancreatic Cancer)
11/2021 - 10/2014
5Residual Neoplasm
05/2021 - 01/2018
5Prostatic Neoplasms (Prostate Cancer)
01/2021 - 02/2012
5Ovarian Neoplasms (Ovarian Cancer)
03/2020 - 03/2011
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020 - 04/2011
5Septic Shock (Toxic Shock Syndrome)
03/2019 - 01/2011
5Brain Ischemia (Cerebral Ischemia)
05/2016 - 01/2014
4Cognitive Dysfunction
05/2022 - 10/2014
4Adenocarcinoma
01/2022 - 01/2018
4Ischemia
10/2021 - 11/2013
4Glioblastoma (Glioblastoma Multiforme)
01/2021 - 09/2015
4Carcinoma (Carcinomatosis)
01/2018 - 08/2010
4Pain (Aches)
10/2017 - 01/2011
4Acute Promyelocytic Leukemia
10/2017 - 09/2009
4Cerebral Hemorrhage
01/2017 - 10/2015
3Poliomyelitis (Polio)
12/2022 - 01/2020

Drug/Important Bio-Agent (IBA)

38Proteins (Proteins, Gene)FDA Link
01/2022 - 10/2008
18Pharmaceutical PreparationsIBA
04/2022 - 06/2012
13Biomarkers (Surrogate Marker)IBA
06/2022 - 10/2008
12Biological ProductsIBA
11/2022 - 01/2009
11Insulin (Novolin)FDA Link
06/2022 - 01/2015
11Messenger RNA (mRNA)IBA
01/2022 - 10/2008
11Glucose (Dextrose)FDA LinkGeneric
09/2021 - 06/2016
11CytokinesIBA
05/2021 - 08/2013
9CarbonIBA
01/2022 - 10/2014
8malic acid (malate)IBA
01/2019 - 07/2015
8ChromiumIBA
01/2019 - 07/2015
8LipopolysaccharidesIBA
08/2014 - 02/2004
7EnzymesIBA
04/2022 - 08/2014
7Polysaccharides (Glycans)IBA
01/2022 - 01/2013
7CholesterolIBA
09/2021 - 11/2005
7Interleukin-6 (Interleukin 6)IBA
01/2021 - 10/2011
7Blood Glucose (Blood Sugar)IBA
12/2018 - 12/2011
7Histone Deacetylase InhibitorsIBA
02/2015 - 02/2012
6Therapeutic UsesIBA
11/2022 - 10/2006
6IonsIBA
01/2022 - 05/2015
6LigandsIBA
01/2022 - 01/2016
6LipidsIBA
09/2021 - 08/2012
6DNA (Deoxyribonucleic Acid)IBA
01/2021 - 06/2009
6Sterol Esterase (Hormone-Sensitive Lipase)IBA
11/2017 - 08/2014
6VorinostatFDA Link
02/2015 - 02/2012
5AcidsIBA
01/2022 - 05/2011
5Transcription Factors (Transcription Factor)IBA
11/2021 - 02/2012
5Peptides (Polypeptides)IBA
02/2020 - 08/2012
5picolinic acid (chromium picolinate)IBA
03/2018 - 01/2015
4Small Interfering RNA (siRNA)IBA
04/2022 - 01/2013
4Anticonvulsants (Antiepileptic Drugs)IBA
03/2022 - 10/2015
4LuciferasesIBA
01/2022 - 05/2017
4GlycopeptidesIBA
01/2022 - 01/2019
4MicroRNAs (MicroRNA)IBA
12/2021 - 09/2016
4CateninsIBA
11/2021 - 05/2017
4ChemokinesIBA
10/2021 - 09/2015
4Triglycerides (Triacylglycerol)IBA
09/2021 - 11/2015
4LDL CholesterolIBA
09/2021 - 11/2015
4Diethylhexyl Phthalate (DEHP)IBA
03/2021 - 01/2019
4Lactic Acid (Lactate)FDA LinkGeneric
01/2021 - 09/2016
4Levetiracetam (Keppra)FDA LinkGeneric
01/2021 - 01/2012
4Doxorubicin (Adriamycin)FDA LinkGeneric
02/2020 - 10/2014
4Fluorouracil (Carac)FDA LinkGeneric
01/2019 - 06/2012
4polyglutamineIBA
06/2017 - 03/2015
4salicylhydroxamic acid (SHAM)IBA
04/2016 - 02/2012
4C-PeptideIBA
11/2015 - 01/2015
4Histone Deacetylases (Histone Deacetylase)IBA
02/2015 - 08/2014
4Histones (Histone)IBA
08/2014 - 02/2012

Therapy/Procedure

39Therapeutics
04/2022 - 01/2011
21Hematopoietic Stem Cell Transplantation
01/2019 - 05/2010
19Drug Therapy (Chemotherapy)
10/2021 - 02/2012
11Radiotherapy
01/2022 - 03/2013
7Punctures
01/2022 - 08/2013
7Transplantation
11/2019 - 06/2009
6Aftercare (After-Treatment)
01/2022 - 12/2010
6Ligation
12/2018 - 08/2013
5Immunotherapy
01/2022 - 01/2020
5Length of Stay
01/2021 - 06/2009
4Induction Chemotherapy
11/2019 - 02/2015